Address

Granite Global Ventures LLC
2494 Sand Hill Road
Suite 100
Menlo Park, CA 94025
United States

Open map


Recent investment activity

KANDO id: 2793

Corporate information

Founders
Official name
Granite Global Ventures LLC
Also known as
GGV
Registration country

Company type

Venture capital firm

Relation

Renamed to

Funds managed

Fund Type Vintage Currency Committed capital IRR x
Granite Global Ventures III LP Venture 2006 USD 400,000,000 17.20 % 2.30 x
Granite Global Ventures II LP Venture 2004 5.90 % 1.49 x

Funding rounds

Investment preferences

Top investment portfolio themes

Actual initial investment stage
N/A (3)

Investment activity status
Not investing

Selected investments

Displaying 1 - 25 of 90
Profile Country Funding
BCD Semiconductor Manufacturing Ltd N/A
Beijing Qikechuangxiang Information Technology Co Ltd N/A
Besunyen Holdings Co Ltd N/A
Biosensors International Group Ltd N/A
Blue Kai Inc N/A
Chamate Co Ltd (Chatea. Chamate Company Ltd) N/A
China Data Group Co Ltd N/A
Chongqing Chaoli Hi-Tech Co Ltd N/A
Chukong Company Inc (Chukong Technologies) Mobile entertainment platform company based in Beijing, China. N/A
Citrus Lane Inc N/A
Daqo New Energy Corp (Mega Stand International Limited ) N/A
DouGuo.com N/A
Dream Castle Inc N/A
Evolv Inc Software-as-a-service platform based call center hiring management solutions. N/A
GB Clean Energy N/A
GENBAND Inc Provider of telecom infrastructure equipment. N/A
Grandhope Biotech Co Ltd N/A
Guava Technologies Inc A biotechnology company providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. N/A
Heptagon Advanced Micro-Optics Pte Ltd N/A
HiSoft Technology International Ltd Provider of outsourced information technology (IT) and research and development services. N/A
Hubs1 Interactive (Shanghai) Co Ltd N/A
HYB Battery Co Ltd N/A
i9yu N/A
INSIDE Secure SA N/A
Intarcia Therapeutics Inc A biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the t N/A

Past employees

Selected Products / Customers

Financials